Related Experiment Video
Updated: Sep 16, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
A critical review on innovative targets for signal disruption in Enterococcus faecalis infection management
Kayeen Vadakkan1, Gajanan Sampatrao Ghodake2, Chin Wei Lai3
1Amala Integrated Medical Research Department, Amala Institute of Medical Sciences (AIMS), Amalanagar, Thrissur, 680555, Kerala, India.
Abstract:
Enterococcus faecalis is a Gram-positive gut-associated microbe that commonly inhabits the human intestine and poses an immense threat to individuals with a compromised immune system, particularly in healthcare settings. It is also delineated for its various virulent factors, such as strong biofilm formation and resistance to multiple medications, which in turn challenge the current treatment strategies. Quorum sensing systems, particularly the Fsr and LuxS systems, play an important role in its virulence by regulating the synthesis of enzymes like gelatinase and serine protease, which help maintain biofilm stability and host tissue encroachment. E. faecalis biofilms are resistant to antimicrobial medications, making the bacteria challenging to eliminate. This review explores E. faecalis quorum sensing systems and their role in biofilm formation, emphasizing these pathways as prospective targets for therapeutic intervention. Emerging techniques, which include the application of phages, probiotics, nanoparticles, and phytochemicals, can inhibit quorum sensing, disrupt biofilm growth and reduce E. faecalis pathogenicity. Targeting these processes may provide beneficial substitutes or complements to standard antibiotics, especially for antibiotic-resistant bacteria. These strategies aid in improving infection control and therapeutic effectiveness toward E. faecalis in healthcare settings.
Insights
Enterococcus faecalis quorum sensing systems (Fsr and LuxS) drive virulence and biofilm formation. Targeting these pathways offers new strategies against this dangerous, antibiotic-resistant gut microbe.
Area of Science:
- Microbiology
- Infectious Diseases
- Bacterial Pathogenesis
Background:
- Enterococcus faecalis is a Gram-positive bacterium prevalent in the human gut.
- It poses significant threats, especially to immunocompromised individuals in healthcare settings, due to virulence factors like biofilm formation and antibiotic resistance.
- Quorum sensing systems, specifically Fsr and LuxS, are crucial for E. faecalis virulence, regulating enzymes that stabilize biofilms and facilitate host tissue invasion.
Purpose of the Study:
- To review the role of E. faecalis quorum sensing systems in biofilm formation and pathogenicity.
- To highlight these systems as potential therapeutic targets for combating E. faecalis infections.
- To explore novel strategies for controlling E. faecalis, particularly antibiotic-resistant strains.
Main Methods:
- Literature review focusing on quorum sensing mechanisms in E. faecalis.
- Analysis of the role of Fsr and LuxS systems in virulence factor production and biofilm development.
- Exploration of emerging therapeutic approaches targeting quorum sensing and biofilm formation.
Main Results:
- Quorum sensing systems (Fsr, LuxS) are key regulators of E. faecalis virulence, including biofilm stability and enzyme synthesis (gelatinase, serine protease).
- E. faecalis biofilms exhibit significant resistance to antimicrobial agents, complicating treatment.
- Novel strategies like phages, probiotics, nanoparticles, and phytochemicals show potential in inhibiting quorum sensing and reducing pathogenicity.
Conclusions:
- Targeting E. faecalis quorum sensing pathways presents a promising therapeutic avenue.
- Alternative and complementary strategies to antibiotics are needed to manage E. faecalis infections, especially antibiotic-resistant strains.
- These novel approaches can enhance infection control and therapeutic outcomes in healthcare settings.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Effectiveness
Endocarditis III: Medical Management
Development of Antibiotic Resistance
Biological Methods for Microbial Control
Combined Effects of Drugs: Synergism
Such synergistic combinations...

